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Abstract
Pheochromocytomas are catecholamine producing tumors arising mostly from chromaffin cells of the adrenal
medulla. The most common clinical presentation is hypertension, mainly in the form of paroxymal episodes.
Cardiovascular manifestations include malignant arrhythmia and catecholamine cardiomyopathy, mimicking acute
coronary syndromes and acute heart failure.
There are reports of pheochromocytomas presenting as acute coronary syndrome and rapidly leading to
cardiogenic shock; the failure of intensive medical treatment in these cases has prompted the need for emergency
adrenalectomy as the only remaining option. We report on a case of complicated pheochromocytoma presenting
as cardiogenic shock, in which emergency adrenalectomy was performed following a total lack of response to
intensive medical treatment.
Background
Pheochromocytomas are catecholamine-producing
tumors arising mostly from chromaffin cells of the adre-
nal medulla.
The most common clinical presentation is hyperten-
sion, mainly in the form of paroxymal episodes. Cardio-
vascular manifestations include malignant arrhythmia
and catecholamine cardiomyopathy, mimicking acute
coronary syndromes and acute heart failure. Pheochro-
mocytoma may constitue a clear medical emergency,
and differential diagnosis poses a major challenge.
There are reports of pheochromocytomas presenting
as acute coronary syndrome and rapidly leading to car-
diogenic shock; the failure of intensive medical treat-
ment in these cases has prompted the need for
emergency adrenalectomy as the only remaining option.
The literature contains few papers discussing the
emergency surgical treatment of pheochromocytoma.
We report on a case of complicated pheochromocytoma
presenting as cardiogenic shock, in which emergency
adrenalectomy was performed following a total lack of
response to intensive medical treatment.
Case presentation
The patient was a 31-year-old male, with no known
drug allergies. Pulmonary emphysema and an esophageal
fistula had been diagnosed 7 years earlier. The patient
had a recently diagnosed difficult to treat hypertension
with bisoprolol and enalapril and for the last year had
suffered exertional dyspnea (a recent echocardiography
showed normal EF) and a number of similar episodes
classed as anxiety attacks.
The patient came to the Emergency Service complain-
ing of occipital headache, chest pain and tightness, pal-
pitations, dyspnea and throat constriction, all of a few
hours’ standing; no sweating, nausea or vomiting.
Findings at physical examination were blood pressure
144/85, heart rate 98, Sat O2 100%. The patient was
conscious, alert, cooperative, eupneic at rest; with hydra-
tion and perfusion satisfactory. Neurological findings
were normal, without nuchal rigidity. Cardiorespiratory
examination revealed rhythmic heart sounds, without
murmurs and normal breath sounds. Abdomen was soft,
with normal sounds, non-tender, without megalies or
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show edema or signs of deep-vein thrombosis. Echocar-
diogram revealed sinus rhythm, 70 bpm, axis normal, no
repolarization defects and chest X-ray had not signifi-
cant findings.
During his stay in the Emergency Unit, the patient
was given sublingual lorazepam for suspected anxiety
symptoms. He later displayed intense chest pain,
vomiting and profuse sweating, a marked deterioration
in general condition and poor peripheral perfusion. A
repeat ECG revealed ST segment depression in V1, V2,
V3 and V4 tracings. Troponine was elevated (table 1)
Since acute coronary syndrome was suspected, electro-
cardiographic monitoring was accompanied by high-
flow oxygen therapy, intravenous nitroglycerin perfu-
sion, and administration of enoxaparin 80 mg, aspirin
200 mg and clopidogrel 300 mg. Peripheral perfusion
remained poor, the patient complained of intense
headache and blood pressure suddenly fall down with-
out previous hypertensive episode. He also displayed
rhythmic wide-complex tachycardia, which was con-
verted to narrow-complex by intravenous administra-
tion of a bolus dose of amiodarone (2 ampoules). The
patient was given 2 cc of morphine chloride and devel-
oped an accelerated idioventricular rhythm (figure 1);
an emergency coronary angiography was performed
with evidence of normal coronary arteries and severe
depression of left ventricle function with an exertion
fraction of 28%.
The patient was placed in intensive care, where after
24 hours his persistently poor condition led to intuba-
tion and mechanical ventilation. On admission to inten-
sive care, his APACHE II score was 10. He subsequently
developed acute heart failure with cardiogenic shock,
which failed to respond to inotropic sympathomimetic drugs. An echocardiography revealed a LVEF of 20%,
prompting emergency implantation of intra-aortic bal-
loon pump counterpulsation. A pheochromocytoma cri-
sis was suspected because of the previous history of
hypertension in a young patient and the finding of nor-
mal coronaries in the coronary angiography. An emer-
gency abdominal CT scan revealed a left adrenal mass
measuring roughly 6 cm and displaying focal necrosis
(figure 2); the diagnosis was suspected complicated
pheochromocytoma.
Due to hemodynamic instability and the progressive
development of multiple organ failure despite intensive
medical treatment, the therapeutic choice lay between
extracorporeal membrane oxygenation (ECMO) and
emergency vs. delayed surgery. Since no ECMO system
was immediately available it was decided, following con-
sultation with the duty surgeon and careful risk assess-
ment (high intraoperative mortality in a patient with a
life threatening condition), that emergency surgery
should be performed.
Table 1 Preoperative laboratory values of the patient
Leucocytes 20.55 × 10
3/μl
Neutrophyls 84.9%
Hemoglobine 18.9 g/dl
Hematocrite 51.2%
Platelets 313 × 10
3/μl
TTPa ratio 0.8
INR 1.0
Glucose 44.16 mmol/l
Sodium 142 mmol/l
Potasium 3.8 mmol/l
AST 56 UI/l
Tirosine 1.57 ng/dl
34.6 mg/l
Creatinine 5.49 ng/ml
I - Troponine 128.48 μmol/l
RCP
Figure 1 ECG tracings during intense chest pain and
hypotension episode showing a accelerated idioventricular
rhythm.
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approach through left subcostal laparotomy incision was
performed; following by careful separation of surround-
ing structures, early ligatureo ft h ei p s i l a t e r a la d r e n a l
vein and tumor removal plus adrenalectomy (figure 3)
Although the patient displayed no hypertensive crisis
prior to tumor removal, he later developed hypotension
which responded well to crystalloid infusion.
Histopathology was reported as a multifocal pheochro-
mocytoma with focal necrosis and hemorrhage. Post-
surgical clinical progress was good. The hydroelectroly-
tic balance was restored under constant monitoring.
After 12 hours, the patient was extubated, the intra-aor-
tic balloon was withdrawn and vasoactive amine thearpy
was stopped. Five days after surgery, the patient was
transferred to the ward, where oral tolerance therapy
was started. He was then placed in the care of the Endo-
crinology Unit, for subsequent observation (table 2) and
management.
Disscusion
Although pheochromocytomas are rare tumors, a rela-
tively high prevalence (up to 0.05%) has been reported
in autopsy studies, suggesting that many tumors are
missed, resulting in sudden death or premature mortal-
ity [1].
Sporadic forms of pheochromocytoma are the most
common (90%), and are usually diagnosed in individuals
aged 40-50 years. However, hereditary forms can also
occur, in association with familial syndromes (e.g. Von
Hippel-Lindau syndrome, multiple endocrine neoplasia
type 2, and neurofibromatosis type 1); these are usually
diagnosed before age 40, and in most cases require
genetic testing.
Pheochromocytoma is often referred to as the great
mimic, and differential diagnosis is rendered complex by
the very wide range of clinical symptoms reported [2]
Whilst pheochromoytoma is found in less than 1% of
patients with hypertension, between 77% and 98% of
patients with pheochromocytoma are hypertensive.
Pheochromocytoma may present as a real medical
emergency, mainly where there are complications [3].
Some patients present with unexplained orthostatic
hypotension, which, on a background of hypertension,
provides an important diagnostic clue. Hypotension may
even be accompanied by shock, usually due to intravas-
cular volume depletion, abrupt cessation of catechola-
mine secretion due to tumor necrosis, desensitization of
adrenergic receptors, or hypocalcemia.
The serious and potentially lethal cardiovascular com-
plications of these tumors are due to the potent effects
of secreted catecholamines [4]. Pheochromocytoma may
present as acute heart failure and pulmonary edema,
Figure 2 Abdominal CT scan: a solid mass measuring 5.5 × 5 ×
4 cm is visible, touching the left adrenal gland and the cauda
pancreatis; the mass contains varying focal densities consistent
with bleeding.
Figure 3 Tumor specimen measuring 4.8 × 4.5 cm.
Table 2 Postoperative 24-h urinary catecholamines
values
Epinephrine 217.80 nmol/day (0.0 - 123)
Norephrine 233.64 nmol/day (0.0 - 504.0 9)
Dopamine 536.25 nmol/day (0.0 - 3237.0)
Normetanephrine 4622.14 nmol/day (400.0 - 2424.0)
Metanephrine 786.35 nmol/day (264.0 - 1729.0)
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acute electrocardiographic changes mimicking acute
myocardial infarction (AMI) [6,7], malignant cardiac
arrhythmia and even dissecting aortic aneurysm.
Other cardiovascular complications of pheochromocy-
toma include sudden death, heart failure due to toxic
cardiomyopathy, hypertensive encephalopathy, acute
cerebrovascular accident or neurogenic pulmonary
edema [8-10].
The most appropriate diagnostic tests for patients with
suspected pheochromocytoma remain a matter of some
debate. Biochemical presentation of excessive produc-
tion of catecholamines is an essential step for the diag-
nosis of pheochromocytoma. Traditional biochemical
tests include meaurements of urinary and plasma cate-
cholamines, urinary metanephrines (normetanephrin
and metanephrine), and urinary vanillylmandelic acid
(VMA); these tests have a sensitivity of over 76%. Mea-
surements of plasma-free metanephrines (normeta-
nephrine and metanephrine) represent a more recently
available test. However, since catecholamine release is
often paroxysmal, a single measurement may give a false
sense of security. Sensitivity may be improved by repeat-
ing tests two or more times, and especially following a
paroxysmal episode.
Other valuable diagnostic procedures include nuclear
magnetic resonance imaging (which visualizes 90% of
adrenal pheochromocytomas) and radio-labeled metaio-
dobenzylguanidine (MIBG) scanning, due to the particu-
lar affinity of this substance for chromaffin tissues.
Complete abdominal CT scan may be very valuable in
emergency situations; given a strong clinical suspicion,
the presence of an adrenal mass is highly indicative of
pheochromocytoma.
With regard to surgical treatment, elective surgery is
the ideal option, accompanied by appropriate preopera-
tive medical treatment; if the procedure is undertaken
by an experienced anesthesiologist and a skilled surgeon,
operative mortality is less than 1% [11]. However, in
extreme conditions (e.g. shock due to a hemorrhagic
necrosis or rupture of a pheochromocytoma), where
hemodynamic stabilization and adequate medical pre-
treatment are not possible, progressive multiple organ
failure may leave emergency tumor resection as the only
option.
The major aim of medical pretreatment is to prevent
catecholamine-induced, serious, and potentially life-
threatening complications during surgery, including
hypertensive crises, cardiac arrhythmias, pulmonary
edema and cardiac ischemia. Traditional management
strategies include the blockade of alpha-adrenoceptors;
phenoxy-benzamine is mostly preferred for this purpose,
since it blocks alpha-adrenoceptors non-competitively,
although doxazosin is also widely used. Other alternative
drugs for preoperative management are labetalol (a
combined alpha- and beta-adrenoceptor blocker) or cal-
cium-channel blockers (dihydropiridines), used either
alone or in combination with adrenoceptor blockers.
Metirosine (alpha-methyl-paratyrosine), which blocks
catecholamine synthesis, is also occasionally used.
Medical treatment usually lasts for around 10-14 days.
The alpha-adrenoceptor blocker dose is periodically
increased, and a beta-adrenoceptor blocker is added
after the first few days of alpha-adrenergic blockade; this
treatment is particularly useful in patients with tachyar-
rhythmias. Additional preoperative measures include
increasing salt and fluid intake (to reduce the risk of
orthostatic and postoperative hypotension), maintaining
blood pressure at or below 160/90 mm Hg, reducing the
frequency of ventricular extrasystoles (<1 every 5 min-
utes) and avoiding electrocardiographic ST segment
changes and T-wave inversions for one week prior to
surgery [12].
Any rise in blood pressure during surgery can be con-
trolled by bolus or by continuous infusion of phentola-
mine, sodium nitroprusside or nicardipine, whilst
tachyarrhythmias can be treated by infusion of esmolol.
Laparoscopic removal of adrenal and extra-adrenal
pheochromocytomas is now the preferred surgical tech-
nique at experienced centers, since it reduces postopera-
tive morbidity, hospital stay, and expense compared
with laparotomy [13-15], with a complication rate of
< 8 %a n dac o n v e r s i o nr a t eo f5 %[ 1 6 ] .H o w e v e r ,o p e n
surgery may be necessary in extreme emergencies invol-
ving hemodynamic instability, where rapid action is cru-
cial to patient survival.
After surgery, patients need to be under close surveil-
lance for the first 24 hours, either in a recovery room or
in the intensive care unit. The two major postoperative
complications are hypotension and hypoglycemia. Post-
operative hypotension is due to the abrupt fall in circu-
lating catecholamines after tumor removal in the
continuing presence of alpha-adrenoceptor blockade (by
phenoxybenzamine). Treatment consists of fluid replace-
ment and occasionally intravenous ephedrine. If ephe-
drine infusion is ineffective, vasopressin might be used.
The risk of hypoglycemia is related to rebound hyperin-
sulinemia due to the recovery of insulin release after
tumor removal.
Although there are few reports in the literature, tumor
removal is known to prompt a reversal of cardiomyopa-
thy and associated symptoms [4,17]; however, if the
pheochromocytoma has remained occult over a longer
period, heart transplant may be the only definitive
solution.
A number of authors have reported on the use of
extracorporeal membrane oxygenation (ECMO) as a res-
cue strategy in patients with pheochromocytoma
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to intensive medical treatment, as an intermediate step
prior to elective surgery [18-20].
With regard to the timing of surgery, a number of
authors recommend emergency adrenalectomy whenever
there is progressive deterioration of the patient’sh e m o -
dynamic status or multiple organ failure despite maxi-
mal medical treatment [21,22].
Conclusion
The initial rapid differential diagnosis in a young patient
displaying clinical symptoms of acute coronary syndrome
progressing to acute heart failure led to diagnostic ima-
ging procedures which revealed a complicated adrenal
pheochromocytoma; emergency surgery was seen as the
only viable option, given clinical evidence of cardiogenic
shock not responding to inotropic sympathomimetic
drugs or emergency implantation of intra-aortic balloon
pump counterpulsation. Although the first option was to
continue intensive medical therapy and apply extracor-
poreal membrane oxygenation, the patient’s declining
hemodynamic status - coupled with the fact that no
ECMO system was immediately available - finally led to
emergency surgery within the first 24-48 hours. Good
perioperative anesthesia management and a laparotomy-
based surgical approach - due to the patient’su n s t a b l e
condition - enabled tumor removal and, within a few
days, complete reversal of clinical symptoms and progres-
sive patient recovery. Therefore, we remark the impor-
tance of emergency adrenalectomy in patients with a
complicated adrenal pheochromocytoma.
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